Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary: grading the credibility of molecular evidence for complex diseases.

Literature DB >> 16540537

Commentary: grading the credibility of molecular evidence for complex diseases.

John P A Ioannidis¹.

Abstract

Mesh：

Year: 2006 PMID： 16540537 DOI： 10.1093/ije/dyl003

Source DB: PubMed Journal: Int J Epidemiol ISSN： 0300-5771 Impact factor: 7.196

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. Molecular bias.

Authors: John P A Ioannidis
Journal: Eur J Epidemiol Date: 2005 Impact factor: 8.082

Review 2. Genomics meets HIV-1.

Authors: Amalio Telenti; David B Goldstein
Journal: Nat Rev Microbiol Date: 2006-10-09 Impact factor: 60.633

3. Lower prevalence of common filaggrin mutations in a community sample of atopic eczema: is disease severity important?

Authors: Robert Gruber; Andreas R Janecke; Daniela Grabher; Elisabeth Horak; Matthias Schmuth; Peter Lercher
Journal: Wien Klin Wochenschr Date: 2010-09-27 Impact factor: 1.704

4. Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication.

Authors: Rolf Weitkunat; Etienne Kaelin; Grégory Vuillaume; Gerd Kallischnigg
Journal: BMC Med Res Methodol Date: 2010-05-28 Impact factor: 4.615

5. GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity, and cancer risk.

Authors: Zhiqiang Hong; Changwei Tian; Xingliang Zhang
Journal: Mol Biol Rep Date: 2012-10-17 Impact factor: 2.316

6. Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus.

Authors: Chirag J Patel; Rong Chen; Keiichi Kodama; John P A Ioannidis; Atul J Butte
Journal: Hum Genet Date: 2013-01-20 Impact factor: 4.132

Commentary: grading the credibility of molecular evidence for complex diseases.

1. Molecular bias.

Review 2. Genomics meets HIV-1.

3. Lower prevalence of common filaggrin mutations in a community sample of atopic eczema: is disease severity important?

4. Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication.

5. GPX1 gene Pro200Leu polymorphism, erythrocyte GPX activity, and cancer risk.

6. Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus.

Review 7. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls.

Review 8. Schizophrenia genetics: the search for a hard lead.

9. Identifying rarer genetic variants for common complex diseases: diseased versus neutral discovery panels.

10. A searchable database of genetic evidence for psychiatric disorders.